Kristen Baltgalvis

Kristen Baltgalvis

Company: Vividion Therapeutics

Job title: Director of Biology


Utilizing Covalent Chemistry to Validate New E3 Ligases for Targeted Degradation 11:30 am

Overview of Vividion’s chemoproteomic platform for the discovery of new drug targets Our approach for targeted protein degradation and the discovery of covalent ligands for enabling new E3 ligases In vitro and in vivo data supporting the use of a covalent Cullin-based degrader against ARRead more

day: Day 2 Track 1 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.